Director John F. Crowley resigns from Intellia Therapeutics Board

Intellia Therapeutics, Inc.

John F. Crowley resigned from the Board and its committees effective December 5, 2023.
He served on Nominating and Governance and Compensation and Talent Development Committees.
Resignation is not due to any disagreement with the Company on operations, policies, or practices.
No replacement has been announced as of the filing date.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

John F. Crowley

Board of Directors

NTLA · Intellia Therapeutics, Inc.

Effective: 2023-12-05
Filed: December 6, 2023, 6:59 PM ET

On December 5, 2023, John F. Crowley notified Intellia Therapeutics, Inc. (the “Company”) of his intent to resign from the Board of Directors (the “Board”) of the Company and its committees, effective December 5, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

John F. Crowley resigned as Board of Directors at Intellia Therapeutics, Inc..

Action: resigned
Role: Board of Directors

Exact text from the filing

On December 5, 2023, John F. Crowley notified Intellia Therapeutics, Inc. (the “Company”) of his intent to resign from the Board of Directors (the “Board”) of the Company and its committees, effective December 5, 2023.

View on SEC.gov

Intellia Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-23-289530

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.